Summary
- Current Price
- As of today, INBX price is $88.37, down -8.91% on
- Current Price All-Time High
- INBX price is currently -43.09% below its historical high of $155.29 set on
- Market Cap
- INBX current market cap is $1B, up +275.30% over the past 365 days
- Revenue
- INBX current annual revenue is $1.30M, up +550.00% year-over-year
- Next Earnings
- The next earnings release for INBX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Inhibrx Biosciences, Inc. |
| Ticker | NASDAQ: INBX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | inhibrx.com |
| Employees | 156 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $88.37 | |
| Price, 1D Change | -8.91% | |
| $1B | ||
| - | ||
| - | ||
| 2.53 | ||
| $1.30M | ||
| Revenue, 1Y Change | +550.00% | |
| -$9.04 | ||
| EPS, 1Y Change | -107.76% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | INXBV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$9.04 | ||
| EPS Estimate | -$9.26 | N/A |
| EPS Est. Change | -2.40% | N/A |
| $1.30M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $88.37 | |
| Price Target | $277.50 | - |
| Price Tgt. Change | +214.02% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $111.60 | $116.58 | +4.47% | |
| -$9.01 | -$9.04 | -0.37% | |
| -$9.26 | N/A | -2.40% | |
| -$6.30 | N/A | +30.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $100.00K | $200.00K | +100.00% | |
| $1.30M | $1.30M | 0.00% | |
| - | N/A | - | |
| $57.18M | N/A | +4,298.08% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $88.37 | |
| $86.11 | ||
| $90.67 | ||
| $80.46 | ||
| $91.00 | ||
| $0.16 | ||
| 2.53 | ||
| $6.15 | ||
| 48.84 | ||
| 67.73% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.30M | ||
| -$9.04 | ||
| -$1.18M | ||
| -91.00% | ||
| -$135.03M | ||
| -10.39% | ||
| -$140.06M | ||
| -10.77% | ||
| -$132.54M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 13.39 | ||
| 3.93 | ||
| 3.93 | ||
| - | ||
| - | ||
| 1.06 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| -24.55 | ||
| -10.74 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $7.99M | ||
| $124.22M | ||
| $146.48M | ||
| $132.83M | ||
| $138.49M | ||
| $33.80M | ||
| $107.01M | ||
| $2.33M | ||
| $5.94M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $141.36M | ||
| $133.84M | ||
| $2.48M | ||
| $23.30M | ||
| $2.48M | ||
| $0.00 | ||
| $2,000.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$129.79M | ||
| -$28.00K | ||
| $101.45M | ||
| $31.00K | ||
| -$129.83M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Stifel | ||
| JMP Securities | → | |
| JMP Securities | → | |
| Citizens Capital Markets | → | |
| JMP Securities | → | |
| JMP Securities | ||
| JMP Securities | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| JMP Securities |
Analyst sentiment
Institutional ownership
No data
Screeners with INBX
FAQ
- What is the ticker symbol for Inhibrx Biosciences, Inc.?
- The ticker symbol for Inhibrx Biosciences, Inc. is NASDAQ:INBX
- Does Inhibrx Biosciences, Inc. pay dividends?
- No, Inhibrx Biosciences, Inc. does not pay dividends
- What sector is Inhibrx Biosciences, Inc. in?
- Inhibrx Biosciences, Inc. is in the Healthcare sector
- What industry is Inhibrx Biosciences, Inc. in?
- Inhibrx Biosciences, Inc. is in the Biotechnology industry
- What country is Inhibrx Biosciences, Inc. based in?
- Inhibrx Biosciences, Inc. is headquartered in United States
- When did Inhibrx Biosciences, Inc. go public?
- Inhibrx Biosciences, Inc. initial public offering (IPO) was on May 29, 2024
- Is Inhibrx Biosciences, Inc. in the S&P 500?
- No, Inhibrx Biosciences, Inc. is not included in the S&P 500 index
- Is Inhibrx Biosciences, Inc. in the NASDAQ 100?
- No, Inhibrx Biosciences, Inc. is not included in the NASDAQ 100 index
- Is Inhibrx Biosciences, Inc. in the Dow Jones?
- No, Inhibrx Biosciences, Inc. is not included in the Dow Jones index
- When was Inhibrx Biosciences, Inc. last earnings report?
- Inhibrx Biosciences, Inc.'s most recent earnings report was on August 13, 2026
- When does Inhibrx Biosciences, Inc. report earnings?
- The next expected earnings date for Inhibrx Biosciences, Inc. is November 13, 2026
Data Sources & References
- INBX Official Website inhibrx.com
- INBX Profile on Yahoo Finance finance.yahoo.com/quote/INBX
- INBX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/inbx